Literature DB >> 32487898

Rheumatologic Disorders and the Nervous System.

Pantelis P Pavlakis.   

Abstract

PURPOSE: This article describes the neurologic manifestations of systemic autoimmune diseases. RECENT
FINDINGS: Systemic autoimmune diseases can be associated with a wide spectrum of neurologic comorbidities involving the central and peripheral nervous systems. Systemic lupus erythematosus (SLE) can be associated with a number of manifestations predominantly affecting the central nervous system (CNS), whereas peripheral neuropathy is less common. Sjögren syndrome can be associated with peripheral neuropathy in 10% of cases and CNS disease in 2% to 5% of cases. The risk of stroke is increased in SLE, rheumatoid arthritis, temporal arteritis, psoriatic arthritis, and ankylosing spondylitis. Systemic vasculitides present most commonly with mononeuritis multiplex but can also affect the CNS. Cognitive dysfunction is a common symptom among patients with systemic autoimmune diseases, most commonly seen in patients with SLE or Sjögren syndrome.
SUMMARY: Neurologic manifestations of systemic autoimmune disease are important to recognize, as they may often be the presenting manifestation leading to diagnosis of the systemic disease or may be associated with increased morbidity, other complications, or mortality. Timely diagnosis and institution of appropriate treatment, often requiring multidisciplinary care, is essential to minimize morbidity and decrease the risk of permanent neurologic deficits.

Entities:  

Mesh:

Year:  2020        PMID: 32487898     DOI: 10.1212/CON.0000000000000856

Source DB:  PubMed          Journal:  Continuum (Minneap Minn)        ISSN: 1080-2371


  2 in total

1.  Central Nervous System (CNS) and Systemic Autoimmune Disease: Coexistence or More?

Authors:  Deepti Vibha; Rajesh Kumar Singh
Journal:  Ann Indian Acad Neurol       Date:  2022-02-09       Impact factor: 1.714

Review 2.  Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management.

Authors:  Elia Sechi; Eoin P Flanagan
Journal:  Front Neurol       Date:  2021-07-07       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.